ArticleEJHaem2021

Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease.

Al-Ola Abdallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.